Harry Penner

Harry Penner

Net worth: 83 979 $ as of 2026-10-30

80 year
Health Technology
Commercial Services
Consumer Services

Profile

Harry H.
Penner
was the founder of Nascent BioSciences Inc. (founded in 2001) where the title held was Chairman & Chief Executive Officer.
Mr. Penner was the founder of Immedica Pharma US, Inc. (founded in 2003) with the title of Director.
Mr. Penner was the founder of QCDx LLC (founded in 2017) holding the title of Chairman.
Mr. Penner was the founder of Melinta Subsidiary Corp.
(founded in 2000) where the title was Director from 2000 to 2009.
Mr. Penner was the founder of New Haven Pharmaceuticals, Inc. (founded in 2008) with the title Executive Chairman from 2012 to 2016.
Mr. Penner was also the founder of Prevention Pharmaceuticals, Inc.,Affinimark Technologies, Inc.,RHEI Pharmaceuticals, Inc.,Virscio, Inc.,Omax Health, Inc...
Mr. Penner was previously Chairman & Chief Executive Officer at Nascent BioScience LLC since 2001.
Mr. Penner is Chairman at Celldex Therapeutics, Inc. starting in 2025.
Mr. Penner is Director at MAKScientific LLC.
Mr. Penner is Director at CaroGen Corp.
Mr. Penner is Director at Neurovail, Inc. Mr. Penner is Director at Aria Neurosciences, Inc. Former positions include Vice Chairman, President & Chief Executive Officer at Neurogen Corp.
from 1999 to 2001.
Chairman at Celldex Therapeutics, Inc. (Old).
Chairman at Connecticut Technology Council.
Chairman at Connecticut Board of Governors for Higher Education.
Co-Chairman at Connecticut United for Research Excellence, Inc. Director at AVANT Immunotherapeutics, Inc. from 1997 to 2008.
Director at Genaissance Pharmaceuticals, Inc. Lead Director at Altus Pharmaceuticals, Inc. from 2006 to 2009.
Director at Ikonisys, Inc. Director at Connecticut Business & Industry Association.
Executive Vice President at Novo Nordisk A from 1988 to 1993.
President & EVP-North America at Novo Nordisk North America, Inc. from 1988 to 1993.
Education includes undergraduate degree from the University of Virginia, graduate degrees from Fordham University and New York University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-24 2,790 ( 0% ) 83 979 $ 2026-10-30

Harry Penner active positions

CompaniesPositionStart
CELLDEX THERAPEUTICS, INC. Chairman 2025-06-04
Founder -
Nascent BioScience LLC
Chief Executive Officer 2000-12-31
Founder -
Director/Board Member -
Director/Board Member -
Neurovail, Inc.
Director/Board Member -
Director/Board Member -

Former positions of Harry Penner

CompaniesPositionEnd
Founder 2016-08-31
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
See the detail of Harry Penner's experience

Education of Harry Penner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

31

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies31

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Connecticut Board of Governors for Higher Education

Commercial Services

Health Technology

Commercial Services

Novo Nordisk North America, Inc.

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Nascent BioScience LLC

Health Technology

Neurovail, Inc.

Health Technology